NCT07140133View on ClinicalTrials.gov

Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

Not yet recruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
High Bleeding Risk PatientsCardiologyStent ImplantationDAPT(Dual Antiplatelet Therapy)
Trial Locations (1)

38700

Chu Grenoble Alpes, Grenoble

All Listed Sponsors
collaborator

Sino Medical Sciences Technology Inc.

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT07140133 - Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient | Biotech Hunter | Biotech Hunter